SCHEMBL15918582

SCHEMBL15918582

O=C(O)c1ccc(NC(=O)c2cc(Cl)c(C(F)(F)F)cc2Oc2ccc(F)cc2Cl)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15561766 0.90 — —
SCHEMBL15917918 0.89 — —
SCHEMBL15561883 0.88 — —
SCHEMBL21130229 0.85 — —
SCHEMBL15917734 0.85 — —
SCHEMBL15561719 0.83 — —
SCHEMBL15561890 0.82 — —
SCHEMBL15933725 0.82 — —
SCHEMBL15561837 0.81 — —
SCHEMBL22203199 0.80 SCN8A (0.57) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9421196-B2 Amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2016-08-23 — — US disclosed
US-20150328196-A1 AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED 2015-11-19 — — US disclosed
US-9108903-B2 Amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-08-18 — — US disclosed
US-20140221435-A1 AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-08-07 — — US disclosed
Send feedback